The objective of our study is to highlight the therapeutic effect and mechanism of action by which purified Flaxseed hydrolysate (PFH) which is a lignan rich fraction exerts its anticancer activity on a human breast cancer cell line (T47D) and in mice bearing tumor. HPLC analysis of PFH of six flaxseed cultivars had shown that PFH of the cultivar Giza 9 (PFH-G9) contains the highest concentration of SDG (81.64 mg/g). The in vitro cytotoxic potentiality of PFH's of six flaxseed cultivars was screened against a panel of human cancer cell lines. PFH -G9 showed the most significant cytotoxic activity against ER-receptor positive breast cell lines MCF7 and T47D with IC 50 13.8 and 15.8 µg/ml, respectively. Moreover, PFH-G9 reduced the expression of the metastasis marker, 1-α, metalloproteinases and vascular endothelial growth factor (VEGF), one of the most potent stimulators of angiogenesis, while it increased the caspase-3 dependent apoptosis. Our study also showed that dietary intake of 10% of Giza 9 Flaxseeds (FS), fixed oil (FSO) or Flax meal (FSM) twice daily for 3 weeks in mice-bearing solid Ehrlich ascites carcinoma (EAC) resulted in reducing the tumor volume, the expression of estrogen, insulin growth factor, progesterone, VEGF and MMP-2, but enhanced expression of caspase-3.
Given the continuous rise in cancer incidence together with the associated high mortality, in addition to the spiraling healthcare costs of treatment, there is always an interest in finding new strategies for its prevention and even treatment. In this respect, there is a substantial tendency for the use of natural compounds as anticancer or chemopreventive agents.
A thousand of studies have demonstrated the role of phytoestrogens as health promotors, and in protecting against or treating cancer 1 . Lignans and their in vivo metabolites, especially enterolactone (ENL) had acquired great interest as potential chemopreventive and therapeutic agent 2 . Lignans are natural plant constituents that are referred to as phytoestrogens. Phytoestrogens are plant constituents that can interfere with the estrogen metabolism. Lignans can modify the estrogen levels through their estrogenic and anti-estrogenic effect. Daily uptake of lignans as a dietary supplements may induce hormonal changes which are of high benefits to females at all ages 3, 4 . Flaxseed is the richest natural source of lignans, as its lignan content is 100 times greater than other lignan containing grains, fruits and vegetables (9-30 mg/g) 5, 6 . Flaxseed lignans were shown to possess potent antitumor activity for hormone-sensitive cancers 7 . Dietary supplementation of flaxseed or its lignan precursor; secoisolariciresinol diglucoside, SDG) for two weeks prevented metastasis of B16BL6 murine melanoma cells in mice 8, 9 . Moreover, 5% flaxseed in the diet inhibited the growth and development of the transgenic prostate adenocarcinoma in mice 10 . Another study has shown that the dietary intake of flaxseed in mice bearing estrogen (ER)-receptor negative human breast cancer (MDA-MB-435), reduced tumor growth and metastasis through down-regulation of insulin-like growth factor 11 . Additionally, flaxseed, its lignan and oil components were also reported to decrease mammary tumor growth at a late stage of carcinogenesis 12, 13 . Also, Dietary intake of flaxseed oil which is a rich source of ω−3 fatty acid suppressed colon tumor in rats particularly in the promotion stage
In vitro study. Cytotoxic screening of the PFH of the six flaxseed cultivars. Table ( 2) shows the IC 50 of all the investigated hydrolysates on 5 cancer cell lines (HELA, TD47, MCF7, MDA-MB231 and HCT116 in addition to 1 normal cell line HFB4. It was detected that all the tested hydrolysates had cytotoxic activity with IC 50 between (12.8-24 .3ug/ml). All the hydrolysates showed less cytoxicity to normal cell line compared to cancer cell lines. PFH from Sakha 2, Giza 9 and Giza 10 have more significant cytotoxic activity against ER-receptor positive human breast cancer cell lines; MCF7 and T47D compared to the effect on the triple negative cell line MDA-MB231. Moderate cytotoxicity was detected by all hydrolysates on colorectal cancer cell line, HCT116. It is also worthy to mention that Sakha 1 had the least significant activity against HELA, MCF7 and T47D cell lines. On the other hand, Sakha 3 had strong activity against HELA, and T47D, while Sakha 4 showed its most pronounced activity against MCF7 and T47D.
PFH of Giza 9 (PFH-G9) which showed a significant cytotoxic activity against both MCF7 and T47D cell lines was chosen for further in vitro investigations. Figure ( 2) illustrates PFH-G9 at IC 50 (15 μg/ml) decreased the expression levels of MMP-2 and MMP-9 mRNA by 92% and 99.5%, respectively compared to the control group. However, treatment of T47D cells with Tamoxifen (TAM) (15 μM) significantly resulted in 6.3-fold and 7.4-fold increase in the expression levels of MMP-2 and MMP-9 mRNA, respectively compared to the control group.
Effect of PFH-G9 on the expression of MMP-2 and MMP-9 in T47D cells.

Effect of PFH-G9on caspase-3 activity in T47D cells.
To investigate the apoptotic effect of PFH-G9 on T47D cells, caspase-3 activity was assessed. PFH-G9 (15 μg/ml) induced an elevation of caspase-3 activity by 35% compared to the control group. Moreover, TAM (15 μM) significantly induced a 62.5% increase in caspase-3 activity compared to the control group, Fig. 3 . Figure 4 shows the treatment of T47D cells with PFH-G9 (15 μg/ml) resulted in a significant decrease in p53 level by 58.5% compared to the control group. Additionally, TAM (15 μM) significantly decreased p53 level by 77.5% compared to the control group.
Effect of PFH-G9on p53 the mutated in T47D cells.
The primers sequences of MMP-2, MMP-9, caspase-3 and p53 are shown in Table ( 3).
Effect of PFH-G9 on VEGF level in T47D cells. PFH-G9 and TAM resulted in a significant decrease in VEGF levels by 16% and 19% respectively compared to the control group Fig. 5 .
In vivo study. Effect on tumor volume. Flaxseeds (FS) and Flax meal (FSM) given as diet twice daily for three weeks to EAC-bearing mice were able to significantly retard tumor growth rate compared to the BD group Fig. 6 . FS and FSM significantly increased the tumor doubling time (TDT; the average days required by the tumor to reach double the initial tumor volume) by 48.7% and 55%, respectively compared to the BD group. In contrast, flaxseed fixed oil (FSO) given as diet twice daily for three weeks to EAC-bearing mice didn't induce any significant change on the tumor doubling time (TDT) compared to the BD feeding group.
Effect on GSH and MDA levels. As shown in Figs 7 and 8, FO, FS and FSM given as diet twice daily for three weeks to EAC-bearing mice didn't result in any significant change in both GSH and MDA levels compared to EAC-bearing group given BD as diet twice daily for three weeks. Regarding estrogen, its expression was reduced by 26, 56 and 67% in FO, FS and FSM respectively compared to the BD group (Fig. 9) . Moreover, FO, FS and FSM diets significantly repressed the expression of Ki-67 by 23, 52 and 72%, respectively compared to the BD group (Fig. 10) . Also, the expression of insulin growth factor was significantly decreased after the administration of FO, FS and FSM as diets by 16, 48 and 61% respectively compared to BD group (Fig. 11) . Additionally, progesterone expression was significantly suppressed by 53 and 72% in animals fed FS and FSM diets respectively compared to the BD group (Fig. 12) . Interestingly, FO, FS and FSM diets significantly enhanced caspase-3 expression by 192%, 404% and 746%, respectively, compared to the BD group (Fig. 13 ). Concerning VEGF, its expression was attenuated by 52%, 89% and 88% respectively, compared to the BD group (Fig. 14) . Moreover, FS and FSM diets significantly mitigated the expression of mmp-2 by 22 and 42% respectively compared to the BD group (Fig. 15) .
GAPDH 5-TGAAGGTCGGAGTCAACGGATTT-3 5-GCCATGGAATTTGCCATGGGTGG-3 Table 3 . The primers sequences of MMP-2, MMP-9, caspase-3 and P53. Values were normalized to GAPDH and were expressed as relative expression levels. 
Discussion
The purified hydrolysates from different cultivars of Flaxseed were tested against three different breast cancer cell lines, two ER + (MCF-7& T47D) and one triple negative (MDA-MB231), in addition to a colorectal (HCT-116) and cervix (HELA) cancer cell lines. Moreover, the cytotoxicity of the extracted hydrolysates were tested against normal cells (HFB4) to ensure their safety. According to the plant screening program of the US National Cancer Institute, for a crude extract to have in vitro cytotoxic activity, its IC 50 value should be less than 20 µg/ml, at incubation period of 48 and 72 hours 18 . On this basis, PFH-G9 hydrolysate showed the most effective cytotoxic activity against HELA, MCF7 and T47D cell lines with IC 50 17.4, 13.8 and 15.8 µg/ml, respectively. The high anticancer activity of PFH-G9 could be attributed to its content of SDG as the HPLC analysis had shown that PFH-G9 contains the highest concentration of SDG (81.64 mg/g) when compared to the other cultivars. A very critical stage in cancer prognosis is the development of tumor cell invasion and metastasis that is responsible for the mortality and morbidity of most cancer patients. Matrix metalloproteinases (MMPs) have a substantial role in the classic hallmarks of cancer including tumor growth and the multistep processes of invasion and metastasis 19 . MMP-2 and MMP-9 were investigated as one of the possible anticancer mechanisms of flaxseed. Our results showed that Table 4 . Effect of FO, FS and FSM given as diet twice daily for three weeks on estrogen receptor, Ki-67, insulin growth factor, progesterone, caspase-3, VEGF and MMP-2 expression in EAC-bearing mice. Quantification of estrogen receptor, Ki-67, insulin growth factor, progesterone, caspase-3, VEGF and MMP-2 staining represent the percent of estrogen receptor, Ki-67, insulin growth factor and progesterone positive cells respectively per total number of cells in a field, across six fields. Values were given as means ± SD (n = 6), a, b and c: Significantly different from BD, FO and FS respectively at p < 0.05 using ANOVA followed by Tukey-Kramer as post-hoc test.
ScientiFic REpoRtS | (2018) 8:544 | DOI:10.1038/s41598-017-18944-0 PFH-G9 significantly attenuated MMP-2 and MMP-9 levels in T47D cells although, TAM an estrogen receptor modulator used in ER positive breast cancer patients treatment significantly enhanced MMP-2 and MMP-9 levels in T47D cells. Similar upregulation of MMP2 and 9 by TAM in T47D cells was previously reported 20 . The decreased levels of MMP-2 and 9 in this study cope well with a previous study which revealed that enterolactone, a mammalian lignan derived from flaxseed down-regulated the metastasis-related MMP-2, MMP-9 and MMP-14 gene expressions in MCF-7 and MDA-MB231 cell lines 2 . In addition, it was reported that administration of TAM together with a physiologic level of estradiol to nude mice bearing breast cancer tumors (MCF7) caused an increase in endostatin, MMP-2 and MMP-9 levels compared with estradiol treatment only 21 . However, it was found the proliferation of ER beta-positive colon cancer cell line (HT-29) was inhibited by TAM only in high concentrations where it could bind to ER beta to down-regulate the expression of MMP-7 22 . VEGF has a pivotal role in regulation of angiogenesis, a physiological process which is very essential to survival of cancer cells, together with cell proliferation and migration 23 . Cancer usually enhances VEGF expression, increasing its concentration due to tumor aggression and the poor prognosis, hence VEGF is involved in cancer pathology 24 . In the present study, significant decrease in VEGF expression was detected after treatments with PFH-G9 and TAM. These data are in harmony with a previous study which revealed that flaxseed and its lignans enterodiol and enterolactone have the potential to decrease angiogenesis in vitro and in vivo via reducing the estradiol-induced VEGF secretion in MCF-7 cells and tumor explants, respectively 25 . Apoptosis (or Programmed Cell Death Type I) is as a safeguard system preventing metastasis at all crucial steps and preventing cancer progression 26 . Apoptosis is a caspase-dependent process which has a direct effect on the development, differentiation and proliferation of cancer. Many researches demonstrated that caspase 3, the executioner caspase, has a vital role in controlling the cell destiny, through the regulation of apoptosis, it was screened to ascertain the oncolytic activity of PFH-G9 in T47D cells. Caspase-3 significantly increased by treatment with either PFH-G9 or TAM 27 . P53 is the most pivotal tumor suppressor gene encoding a sequence-specific transcriptional regulator that controls a plethora of biological functions, including cell-cycle progression, senescence, differentiation, DNA repair, and apoptosis 28 . Normal p53 function was shown to be crucial in the induction of apoptosis in human and murine cells following DNA damage 25 . P53 is the most commonly mutated tumor-suppressor gene in human cancers. The possible role of p53 in the induction of apoptosis by PFH-G9 was investigated. Our data manifested that both PFH-G9 and TAM significantly decreased p53 levels in T47D that expresses mutant p53 in T47D of breast cancer cell line that led to massive apoptosis. Contrary to our results, a previous study showed that flaxseed treatment significantly upregulated p53 mRNA in MCF-7 and MDA-MB-231 cells, thereby inducing apoptosis 29 . The reduction of P53 expression in flaxseed-treated T47D while upregulation of expression in MCF7 treated cells is advantageous for both cell lines as T47D cells has mutant P53 and MCF7 has wild type P53. These data are in agreement with those reported before, which stated that mutant p53 silencing which specifically targets mutant p53 in T47D cells induced massive apoptosis as evidenced by morphological cell blebbing, PARP cleavage, and annexin V/PI staining, however, apoptosis was not observed in MCF-7 or MCF-10A cells that express only wild type 20, 30 . The study was further extended to study the oncolytic effect of different flaxseed diet modalities FO, FS, and FSM diets in EAC-bearing mice. FS and FSM were found to repress the tumor growth. Moreover, all flaxseed diets; FO, FS, and FSM significantly reduced the expression of Ki-67; a nuclear protein expressed in proliferated cells and is used as cell proliferation marker 31 . Many studies have asserted the antitumor activity of dietary flaxseed [32] [33] [34] . Our data revealed that the three dietary formulation significantly reduced the expression of IGF-1; a tyrosine kinase known to be mitogenic, and playing a crucial role in cancer development 35 . In agreement with our results, Chen et al. 11 have shown that flaxseed reduced the developed human breast cancer growth and metastasis in a nude mice model, and this effect is partly due to its down-regulation of insulin-like growth factor I and epidermal growth factor receptor expression. Additionally, flaxseed oil was found to reduce MCF-7 tumor growth partially through IGF-1 signaling pathway 36 . The percentage reduction in tumor growth correlated well with estrogen and progesterone status, where FS and FSM significantly repressed the expression of estrogen and progesterone, while FO on reduced the expression of estrogen. A previous study has shown that FS reduced human breast tumor growth (MCF-7) in athymic mice through the downregulation of ER-and growth factor-mediated cell signaling 37 . Moreover, an early study revealed that flaxseed extracts significantly decreased the production of progesterone in jeg3 tumor cell line 7 . In addition, the in vitro results regarding caspase-3, VEGF and MMP -2 were further confirmed in vivo, where FO, FS and FSM significantly enhanced caspase-3 expression, while they significantly mitigated VEGF and MMP-2 expression.
In conclusion, our results have asserted the antitumor activity of Egyptian flaxseed especially Giza-9 and its dietary formulations that involved apoptotic, antiangiogenic and antimetastatic effects.
Materials and Methods
Chemicals. RPMI-1640 Medium, fetal bovine serum, dimethylsulfoxide (DMSO), Ellman's reagent [5,5-Dithio-bis-(2-nitro bezoic acid)], β-mercaptoethanol, glutathione (GSH), glutathione reductase, sodium dodecyl sulfate (SDS), sodium bicarbonate, 1,1.3,3-tetramethoxypropane, trichloroacetic acid (TCA) and thiobarbituric acid were all purchased from Sigma Aldrich Chemical Co. (St. Louis, MO, USA). Secoisolariciresinol diglucoside (SDG) for HPLC analysis was purchased from ChromaDex (Santa Ana, CA, USA). Triton X-100, penicillin, streptomycin were procured from MP Biochemical (Santa Ana, California, USA). All other chemical reagents and extraction solvents were of analytical grade, and all analysis solvents were of HPLC grade and they Cell Lines. Three human breast carcinoma cell lines; MCF-7, T47D, and MDA-MB231, together with colon carcinoma cell line (HCT-116), cervix cell line (HELA) and normal fibroblast cell line (HFB4) were used in this study. They were obtained frozen in liquid nitrogen (−80 °C) from ATCC (MO, USA). The tumor cell lines were maintained by serial sub-culturing at the National Cancer Institute, Cairo, Egypt in RPMI-1640 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin, and 3 mM/l glutamine. The cells were trypsinized every 3 days. They were cultured in a humidified incubator supplied with 5% CO 2 and temperature 37 °C.
Animals.
Female Swiss albino mice weighing 20-25 g, were obtained from the animal house of National Cancer Institute, Cairo, Egypt. All of the animal handling and study procedures were approved by the research Preparation of purified flaxseed hydrolysates. The seeds of each of the six cultivars of flaxseed (50 gm) were separately crushed in a mill, followed by defatting with n-hexane (3 × 400 ml), at 60 °C, using ultrasonic bath, for 30 min. The defatted powder was then extracted with MeOH (80%) at 60 °C for 1hr (3 × 400 ml). The resulting methanolic extract was filtered, pooled and concentrated under vacuum (at 60 °C).
The methanolic extract in each case was hydrolyzed using NaOH (0.5N) for 3 hr. at room temperature. The hydrolysate solution in each case was then neutralized with acetic acid (0.5N). The neutralized hydrolysates were separately purified on Diaion HP-20 column using water and methanol, as eluents. The methanol fraction was evaporated till dryness and used for HPLC analysis and screening of cytotoxic activity.
Sample preparation for HPLC analysis. About twenty milligram of each of the purified methanol fraction was accurately weighed, transferred to 10 ml volumetric flask, and completed with methanol to 10 ml. The solution was then filtered through 0.45 µm membrane filter and subjected to HPLC analysis. HPLC analysis. HPLC was used to determine the richest hydrolysate in secoisolariciresinol diglucoside (SDG) in each of the 6 cultivars. HPLC analysis was carried out using an Agilent 1100 series HPLC system (Agilent Technologies, Palo Alto, CA), equipped with a quaternary pump G1311A, degasser G1322A, UV Preparation of standard solution. Standard stock solution of pure secoisolariciresinol diglucoside (SDG) was prepared by dissolving 1.0 mg in 10 ml methanol in a volumetric flask. This stock solution was serially diluted to prepare five different concentrations (125, 250, 500, 1000, 2000 µg/ml), which were injected in triplicates for establishing the calibration curve (Fig. 1A) .
Biological Assays
Screening of in vitro cytotoxicity of the purified flaxseed hydrolysates (PFH). Cytotoxicity assay. The PFH samples from the 6 cultivar were subjected to screening for antitumor activity on 5 cancer cell lines; three human breast carcinoma cell lines; MCF-7, T47D, and MDA-MB231, together with colon carcinoma cell line (HCT-116), cervix cell line (HELA) and normal fibroblast cell line (HFB4) using the sulforhodamine B (SRB) colorimetric assay 38 . Each PFH sample was dissolved in DMSO and tested at concentrations of 1, 5, 10, 20 and 50 μg/ml. Tamoxifen (TAM) was used as a positive control at the same concentration range. Final concentration of DMSO in the culture medium was maintained at 0.1% to avoid solvent toxicity. Cells were seeded in 96 well plates at a density of (2 × 10 3 to 2 × 10 5 cells/well) in RPMI-1640 supplemented medium for 24 h, and then Cytotoxicity was expressed as the percent of viable cells relative to cells incubated in the presence of 0.1% DMSO solvent control. The concentration of the PFH inhibiting cell growth by 50% relative to solvent control (IC 50 value) was also determined. Each measurement was performed in triplicate.
RNA Purification and Real-Time polymerase chain reaction (qPCR) Analysis.
To study the effect of treatment of T47D cell line with 15.9 µg/ml of PFH-G9 or TAM (15 µM) on the expression levels of metastatic markers, matrix metalloprotinases 2 and 9 were determined using qPCR. Cells were collected from both the control and the treated and total RNA was extracted following the protocol of the RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Reverse transcription was completed using High capacity cDNA archive kit (Applied Biosystem, California,USA), then real time PCR was performed in triplicate on an ABI 7500 Fast Real-Time PCR System using the GoTaq PCR master mix (Promega, Madison, U.S.A) for detection of the expression of 1-α,metalloproteinase MMP-2 and MMP-9 and p53on a 7900HT fast Real-Time PCR System (Applied Biosystems, California, USA). Fast amplification parameters were as follows: one cycle at 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s, and 60 °C for 1 min. All primers were purchased from Invitrogen (California,USA). Quantitative analysis of data was performed by using the∆∆ Ct method 39 . Values were normalized to GAPDH and were expressed as relative expression levels. Assay of Caspase-3 activity. T47D cells were cultured in 75 cm 3 flasks, left till 70-80% confluent, cells were treated with PFH-G9 (15.8 µg/ml) or TAM (15 µM) and incubated for 48 h. The treated and control cells were lysed in a RIPA lysis buffer containing protease inhibitors. The Caspase-3 activity was assessed following spectrophotometric method at 450 nm in lysate using ELISA kit (Invitrogen, Carlsbad, CA,USA) following the manufacturer's instructions 40 . Each concentration repeated two times and the experiment was carried out three independent times. The activity was calculated relative to the corresponding protein content.
Assay of vascular endothelial growth factor (VEGF-A) level.
VEGF was determined in cell culture medium using eBioscience ELISA kit (San Diego, CA, USA). Cells were plated in 6 well plates with 5*10 4 . After treatment with PFH-G9 (15.8 µg/ml) or TAM (15 µM), the medium was aspirated, centrifuged at 10,000 rpm for 10 min at 4 °C to remove any dead cells. The clear supernatant was used for assay following the manufacturer's instructions 41 .
Protein concentration assay. Protein concentrations were measured in the medium and cell lysate using protein kit (Pierce, Rockford, IL, USA) 42 . The method depends on the binding of Comassie Brilliant Blue G-250 dye with protein and forming a complex which can be measured spectrophotometrically at 595 nm then the concentration was determined using a standard calibration curve.
In vivo experiments. In vivo anticancer activity of Giza 9 cultivar. Forty animals were divided in to 4 groups, each consists of 10 animals. Group I: animals of this group were fed with normal pellets of Basal Diet (BD) and served as control. Group II: animals of this group were fed normal pellets BD containing 10% Flaxseed (FS). Group III: animals of this group were fed on normal pellets containing 10% Flaxseed meal (FSM). Finally, Group IV: animals of this group were fed pellets mixed with 10% Flaxseed oil (FSO). The diet was supplied twice a day for three weeks. The change in weight of the animals of different groups was monitored twice weekly for three weeks Antitumor effect. The change in tumor volume was measured every other day using venire caliber and calculated by the following formula, Tumor volume mm 3 = 0.52 A 2 × B, where A and B denote the minor & major tumor axis, respectively. At the end of the experiment the animals were sacrificed and the tumors were isolated, excised and weighed 43 .
Determination of reduced glutathione (rGSH) and MDA contents in solid tumor. After the last treatment, animals were anesthetized. Tumors were quickly excised, washed with saline, blotted with a piece of filter paper, and homogenized using a Branson sonifier (250, VWR Scientific, Danbury, Connecticut, USA). The homogenates were centrifuged at 800 g for 5 min at 4 °C to separate the nuclear debris, then supernatant was again centrifuged at 10,500 g for 20 min at 4 °C. Levels of glutathione and MDA were determined as previously described by (Ellman 1959 ) 44 and (Draper and Hadley 1990) 45 , respectively.
Immunohistochemical staining (IHC) of estrogen, androgen receptors and KI67 caspase-3, VEGF and MMP-2.
Representative tissue samples were fixed in 10% neutral phosphate-buffered formalin, embedded in paraffin, and sectioned at 5 µm thickness. Sections were incubated with mouse monoclonal anti-estrogen receptors, progestrone receptors, insulin like growth factor, KI 67, caspase-3, VEGF and MMP-2 (Sigma Aldrich Chemical Co., USA) as a primary antibody at a dilution of 1:150 overnight at 4 °C. After rinsing three times, sections were incubated with polymer horseradish peroxidase HRP secondary antibody (Sigma Aldrich Chemical Co., USA) for 1 hr. Immuno-reactivity was detected by the standard avidin-biotin immunoperoxidase method.
Statistical analysis. All data were expressed as mean ± S.D. The difference between the treated samples and the untreated controls was analyzed by one way ANOVA followed by Tukey multiple comparison test in which p < 0.05 was considered as significant. All statistical analysis was performed using GraphPad In Stat, version 5.0 (GraphPad, San Diego, California, USA). Statistical significance was set at p < 0.05.
